Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07738068
PHASE3

Progesterone Luteal Support in Unexplained Infertility Management

Sponsor: Simone Broer

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate whether progesterone in women with unexplained infertility can increases live birth rate. The main research question is: Does luteal phase support with progesterone increase the live birth rate among couples with unexplained infertility? The study compares progesterone with placebo to determine the effectiveness of progesterone in unexplained infertility. Study participants will: * Perform home ovulation tests and maintain a digital diary to record menstrual cycles and study medication use.10 * Take progesterone or placebo twice daily during the luteal phase of each menstrual cycle for up to six months.11 * Continue usual medical care. No additional hospital visits or invasive procedures are required as part of the study.

Key Details

Gender

FEMALE

Age Range

18 Years - 43 Years

Study Type

INTERVENTIONAL

Enrollment

640

Start Date

2026-08-01

Completion Date

2031-01-01

Last Updated

2026-07-30

Healthy Volunteers

No

Interventions

DRUG

Utrogestan® 200 mg Soft Capsule

progesteron versus placebo

DRUG

Placebo soft capsule 200 mg

placebo